If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be ...

Recursion Pharmaceuticals granted inducement RSU awards to 17 new employees under its 2024 Inducement Equity Incentive Plan. The awards are tied to recent hiring activity and are intended as ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of ...

Romeo is a Dead Man turns into a gruesome horror game in this level.

Discover the world of Recursive Self-Improvement (RSI) in AI. From I.J. Good's intelligence explosion to modern self-healing code and clinical applications, explore who is developing it, how it works, ...

AI’s rise feels faster and deeper than past tech shifts—reshaping not just what we build, but how we build, learn, and evolve ...

We recently published a list of the 12 Best AI Stocks to Invest in According to Reddit. In this article, we are going to take a look at where Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stands ...

Here at The Information, we’re always trying to break through the hype to understand how folks are actually using AI in the ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day.

The Biden administration set up the U.S. AI Safety Institute, an office tasked with developing protocols to identify risks posed by AI. Canada, Japan, Singapore, South Korea, the United Kingdom, and ...

OpenAI's GPT-5.2 derived a new formula for gluon interactions, overturning assumptions of zero amplitude and advancing theoretical physics.